William Lewis is Chair and CEO of INSMED Inc. Currently has a direct ownership of 384,960 shares of INSM, which is worth approximately $26.8 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 18,750 shares (Common Stock) at a price of $70.08 per share, resulting in proceeds of $1,314,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 385K
0.22% 3M change
12.78% 12M change
Total Value Held $26.8 Million

William Lewis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
SELL
Open market or private sale
$1,314,000 $70.08 p/Share
18,750 Reduced 4.64%
384,960 Common Stock
Dec 19 2024
BUY
Exercise of conversion of derivative security
$426,750 $22.76 p/Share
18,750 Added 4.44%
403,710 Common Stock
Dec 12 2024
SELL
Open market or private sale
$1,377,374 $73.46 p/Share
18,750 Reduced 4.64%
384,960 Common Stock
Dec 12 2024
BUY
Exercise of conversion of derivative security
$426,750 $22.76 p/Share
18,750 Added 4.44%
403,710 Common Stock
May 14 2024
SELL
Open market or private sale
$566,492 $25.52 p/Share
22,198 Reduced 5.46%
384,125 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
-
42,707 Added 9.51%
406,323 Common Stock
Jan 09 2024
SELL
Open market or private sale
$283,954 $28.72 p/Share
9,887 Reduced 2.65%
363,651 Common Stock
Jan 08 2024
SELL
Open market or private sale
$1,331,040 $29.5 p/Share
45,120 Reduced 10.78%
373,538 Common Stock
Jan 08 2024
BUY
Exercise of conversion of derivative security
$924,508 $20.49 p/Share
45,120 Added 10.28%
393,707 Common Stock
Jan 05 2024
SELL
Open market or private sale
$204,205 $29.26 p/Share
6,979 Reduced 1.83%
373,538 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
37,869 Added 9.05%
380,517 Common Stock
May 17 2023
SELL
Open market or private sale
$128,633 $18.12 p/Share
7,099 Reduced 2.04%
341,345 Common Stock
May 16 2023
SELL
Open market or private sale
$68,374 $18.41 p/Share
3,714 Reduced 1.05%
348,444 Common Stock
May 15 2023
SELL
Open market or private sale
$116,303 $19.23 p/Share
6,048 Reduced 1.69%
352,158 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
93,139 Added 20.64%
358,206 Common Stock
Jan 10 2023
SELL
Open market or private sale
$125,892 $18.0 p/Share
6,994 Reduced 2.57%
265,067 Common Stock
Jan 05 2023
SELL
Open market or private sale
$138,758 $19.8 p/Share
7,008 Reduced 2.73%
249,708 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
22,353 Added 7.59%
272,061 Common Stock
Jul 07 2022
SELL
Open market or private sale
$2,222,122 $23.0 p/Share
96,614 Reduced 27.34%
256,716 Common Stock
Jul 07 2022
BUY
Exercise of conversion of derivative security
$1,561,282 $16.16 p/Share
96,614 Added 21.47%
353,330 Common Stock
May 17 2022
SELL
Open market or private sale
$120,999 $20.18 p/Share
5,996 Reduced 2.29%
255,828 Common Stock
May 16 2022
SELL
Open market or private sale
$62,353 $18.35 p/Share
3,398 Reduced 1.28%
261,824 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
47,598 Added 15.22%
265,222 Common Stock
Mar 23 2022
SELL
Open market or private sale
$2,252,072 $23.31 p/Share
96,614 Reduced 30.75%
217,624 Common Stock
Mar 23 2022
BUY
Exercise of conversion of derivative security
$1,499,449 $15.52 p/Share
96,614 Added 30.65%
218,605 Common Stock

Also insider at

NAMS
NewAmsterdam Pharma Co N.V.
WL

William Lewis

Chair and CEO
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Track Activities on INSM